Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Bristol Myers Squibb - 53 Year Stock Price History | BMY

Historical daily share price chart and data for Bristol Myers Squibb since 1972 adjusted for splits and dividends. The latest closing stock price for Bristol Myers Squibb as of July 29, 2025 is 46.86.
  • The all-time high Bristol Myers Squibb stock closing price was 72.01 on December 02, 2022.
  • The Bristol Myers Squibb 52-week high stock price is 63.33, which is 35.1% above the current share price.
  • The Bristol Myers Squibb 52-week low stock price is 44.00, which is 6.1% below the current share price.
  • The average Bristol Myers Squibb stock price for the last 52 weeks is 52.90.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Bristol Myers Squibb Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 51.8686 54.8444 61.6206 43.5457 46.8600 -14.21%
2024 47.0478 48.5001 57.8864 37.6862 54.6222 15.81%
2023 56.8400 64.1397 66.6779 44.5657 47.1672 -26.14%
2022 63.9462 53.2716 72.0129 53.2716 63.8645 18.98%
2021 53.5966 51.6270 59.1857 46.1693 53.6762 2.88%
2020 50.0407 51.6349 54.9690 37.8254 52.1737 0.41%
2019 40.1213 41.0299 51.9609 34.3333 51.9609 27.74%
2018 44.7465 46.7229 52.9129 38.1579 40.6777 -12.90%
2017 43.4493 44.1070 49.8017 34.9659 46.7000 7.71%
2016 46.4372 48.8370 56.5650 36.5246 43.3576 -13.49%
2015 46.3520 42.3684 51.2374 41.2598 50.1193 19.26%
2014 36.5592 36.1980 43.3728 32.4900 42.0266 14.18%
2013 29.8453 21.9725 37.0340 21.9725 36.8074 69.96%
2012 21.7969 22.3665 23.7819 20.4739 21.6568 -3.80%
2011 18.2018 16.2070 22.5453 15.4173 22.5134 39.44%
2010 15.3676 15.0725 16.8351 13.3548 16.1461 8.74%
2009 12.3642 13.2822 15.0776 9.7392 14.8490 14.83%
2008 11.6132 13.7194 14.2182 9.4704 12.9318 -6.03%
2007 14.7420 13.3030 16.5173 13.1618 13.7614 4.79%
2006 11.8337 11.0762 13.1318 9.9844 13.1318 19.90%
2005 11.3458 11.5824 12.3342 10.0229 10.9523 -6.14%
2004 11.2553 12.9098 13.4772 10.1276 11.6689 -7.24%
2003 10.8210 10.1118 12.5799 8.8915 12.5799 29.14%
2002 12.6245 20.5196 20.7012 8.4455 9.7415 -52.40%
2001 22.1588 26.8037 26.8037 19.6645 20.4672 -26.16%
2000 21.6754 23.7628 27.7174 16.1079 27.7174 17.10%
1999 25.0061 23.7276 28.7413 21.0482 23.6707 -2.80%
1998 19.6712 17.0362 24.3532 16.1697 24.3532 42.95%
1997 13.5800 9.4555 17.5362 9.4555 17.0362 77.07%
1996 7.7996 7.0214 10.1467 6.6545 9.6210 36.62%
1995 5.5674 4.6333 7.0624 4.6135 7.0420 53.30%
1994 4.2979 4.3275 4.7516 3.8646 4.5936 6.11%
1993 4.2644 4.7522 4.7522 3.7526 4.3290 -9.44%
1992 5.0075 6.0645 6.0988 4.3586 4.7803 -21.18%
1991 5.3509 4.4393 6.0645 4.0895 6.0645 35.84%
1990 3.8508 3.6620 4.4739 3.2766 4.4643 24.08%
1989 3.1141 2.7377 3.6358 2.7145 3.5978 28.87%
1988 2.5628 2.5613 2.8070 2.3028 2.7917 14.36%
1987 2.7687 2.4240 3.1602 2.1406 2.4411 2.84%
1986 2.1113 1.7344 2.4811 1.5926 2.3737 35.83%
1985 1.5169 1.3096 1.7710 1.2713 1.7476 30.58%
1984 1.1617 1.0658 1.3383 1.0318 1.3383 28.17%
1983 0.9428 0.8032 1.1686 0.7552 1.0442 30.54%
1982 0.6982 0.6106 0.8713 0.5918 0.7999 31.22%
1981 0.5910 0.5654 0.6627 0.5114 0.6096 9.15%
1980 0.4455 0.3907 0.5696 0.3303 0.5585 40.54%
1979 0.3618 0.3671 0.4028 0.3290 0.3974 7.87%
1978 0.3396 0.3317 0.3991 0.2807 0.3684 10.27%
1977 0.3172 0.3268 0.3511 0.2800 0.3341 1.30%
1976 0.3460 0.3248 0.3927 0.2954 0.3298 2.11%
1975 0.2869 0.2337 0.3431 0.2154 0.3230 40.99%
1974 0.2079 0.2066 0.2500 0.1434 0.2291 11.81%
1973 0.2658 0.2946 0.3070 0.1931 0.2049 -30.94%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $96.687B $48.300B
Bristol-Myers Squibb is a one of the leading global specialty biopharmaceutical companies focused on the development of treatments targeting serious diseases like cancer, inflammatory, immunologic, cardiovascular or fibrotic diseases. Backed by its blockbuster immuno-oncology drug, Opdivo, Bristol-Myers has a strong oncology portfolio, comprising other drugs like Revlimid, Pomalyst, Sprycel, Yervoy and Empliciti. It also has important immunology and cardiovascular drugs like Orencia and Eliquis. It's experiencing growth in both the Eliquis brand and the market, while also advancing its Factor XIa inhibitor program. After the sale of the global Diabetes business to AstraZeneca and the discontinuation of discovery research efforts in virology, it's focusing solely on research in core therapeutic areas like oncology, immuno-oncology, immunoscience, cardiovascular, fibrosis and genetically defined diseases. It acquried Celgene Corporation and MyoKardia. It received regulatory approvals for Reblozyl and Inrebic.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $222.769B 16.63
Amgen (AMGN) United States $162.005B 14.51
Gilead Sciences (GILD) United States $140.601B 14.60
Vertex Pharmaceuticals (VRTX) United States $118.340B 0.00
CSL (CSLLY) Australia $85.154B 0.00
GSK (GSK) United Kingdom $76.456B 9.18
Regeneron Pharmaceuticals (REGN) United States $60.313B 14.64
Alnylam Pharmaceuticals (ALNY) United States $42.349B 0.00
Argenex SE (ARGX) Netherlands $36.426B 99.20
BioNTech SE (BNTX) Germany $27.114B 0.00
Royalty Pharma (RPRX) United States $20.837B 8.80
Insmed (INSM) United States $19.303B 0.00
Biogen (BIIB) United States $18.943B 8.17
Illumina (ILMN) United States $17.394B 33.00
Genmab (GNMSF) Denmark $15.151B 15.49
Genmab (GMAB) Denmark $14.813B 16.61
Incyte (INCY) United States $13.581B 103.18
Moderna (MRNA) United States $13.114B 0.00
Exelixis (EXEL) United States $12.106B 21.55
QIAGEN (QGEN) Netherlands $11.332B 22.05
BioMarin Pharmaceutical (BMRN) United States $11.150B 18.11
Swedish Orphan Biovitrum (BIOVF) Sweden $10.605B 23.46
Ascendis Pharma (ASND) Denmark $10.039B 0.00
Bio-Techne Corp (TECH) United States $9.179B 34.24
Exact Sciences (EXAS) United States $9.062B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.947B 0.00
Roivant Sciences (ROIV) United Kingdom $7.716B 0.00
Legend Biotech (LEGN) United States $7.628B 0.00
Anbio Biotechnology (NNNN) Germany $7.314B 0.00
Halozyme Therapeutics (HALO) United States $7.114B 13.62
Jazz Pharmaceuticals (JAZZ) Ireland $7.102B 6.97
Revolution Medicines (RVMD) United States $6.940B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $6.824B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.723B 23.40
Repligen (RGEN) United States $6.722B 75.25
Nuvalent (NUVL) United States $5.884B 0.00
TG Therapeutics (TGTX) United States $5.714B 149.96
CRISPR Therapeutics AG (CRSP) Switzerland $5.506B 0.00
Guardant Health (GH) United States $5.485B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.451B 0.00
Axsome Therapeutics (AXSM) United States $4.943B 0.00
Telix Pharmaceuticals (TLX) Australia $4.724B 0.00
Vaxcyte (PCVX) United States $4.627B 0.00
Merus (MRUS) Netherlands $4.540B 0.00
Krystal Biotech (KRYS) United States $4.419B 34.06
Cytokinetics (CYTK) United States $4.375B 0.00
Zealand Pharma (ZLDPF) Denmark $4.336B 0.00
Alkermes (ALKS) Ireland $4.312B 11.57
Zai Lab (ZLAB) China $4.298B 0.00
ADMA Biologics Inc (ADMA) United States $4.297B 32.14
Abivax SA (ABVX) France $4.225B 0.00
Avidity Biosciences (RNA) United States $4.165B 0.00
Metsera (MTSR) United States $4.142B 0.00
Akero Therapeutics (AKRO) United States $3.925B 0.00
Arcellx (ACLX) United States $3.890B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.786B 33.26
Viking Therapeutics (VKTX) United States $3.733B 0.00
Scholar Rock Holding (SRRK) United States $3.522B 0.00
PTC Therapeutics (PTCT) United States $3.514B 6.12
Protagonist Therapeutics (PTGX) United States $3.487B 75.01
MoonLake Immunotherapeutics (MLTX) Switzerland $3.487B 0.00
Ascentage Pharma Group - (AAPG) China $3.426B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.136B 0.00
Alvotech (ALVO) Luxembourg $2.958B 16.91
Bavarian Nordic (BVNRY) Denmark $2.896B 15.30
Kymera Therapeutics (KYMR) United States $2.878B 0.00
Immunovant (IMVT) United States $2.867B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.610B 0.00
Ligand Pharmaceuticals (LGND) United States $2.603B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.565B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.551B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.376B 0.00
Apellis Pharmaceuticals (APLS) United States $2.357B 0.00
ImmunityBio (IBRX) United States $2.339B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.237B 0.00
IDEAYA Biosciences (IDYA) United States $2.191B 0.00
Twist Bioscience (TWST) United States $2.189B 0.00
Agios Pharmaceuticals (AGIO) United States $2.154B 0.00
Beam Therapeutics (BEAM) United States $2.095B 0.00
Vericel (VCEL) United States $2.087B 1381.67
Disc Medicine (IRON) United States $2.060B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.053B 13.65
Mesoblast (MESO) Australia $2.039B 0.00
Denali Therapeutics (DNLI) United States $1.980B 0.00
Belite Bio (BLTE) United States $1.976B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.973B 0.00
CG Oncology (CGON) United States $1.971B 0.00
Amicus Therapeutics (FOLD) United States $1.885B 204.00
Apogee Therapeutics (APGE) United States $1.826B 0.00
Certara (CERT) United States $1.796B 33.54
Arcutis Biotherapeutics (ARQT) United States $1.783B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.754B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.705B 0.00
Liquidia Technologies (LQDA) United States $1.694B 0.00
Adaptive Biotechnologies (ADPT) United States $1.612B 0.00
Janux Therapeutics (JANX) United States $1.512B 0.00
Edgewise Therapeutics (EWTX) United States $1.500B 0.00
AbCellera Biologics (ABCL) Canada $1.468B 0.00
Celldex Therapeutics (CLDX) United States $1.461B 0.00
ANI Pharmaceuticals (ANIP) United States $1.441B 14.84
Viridian Therapeutics (VRDN) United States $1.408B 0.00
Celcuity (CELC) United States $1.393B 0.00
89BIO (ETNB) United States $1.392B 0.00
GRAIL (GRAL) United States $1.377B 0.00
Cogent Biosciences (COGT) United States $1.377B 0.00
Travere Therapeutics (TVTX) United States $1.368B 0.00
Sarepta Therapeutics (SRPT) United States $1.362B 0.00
Intellia Therapeutics (NTLA) United States $1.358B 0.00
Dynavax Technologies (DVAX) United States $1.356B 80.64
Biohaven (BHVN) United States $1.333B 0.00
Vera Therapeutics (VERA) United States $1.331B 0.00
NovoCure (NVCR) Jersey $1.301B 0.00
WAVE Life Sciences (WVE) Singapore $1.273B 0.00
Cidara Therapeutics (CDTX) United States $1.264B 0.00
CureVac (CVAC) Germany $1.216B 5.89
MannKind (MNKD) United States $1.204B 24.75
Novavax (NVAX) United States $1.179B 2.75
Praxis Precision Medicines (PRAX) United States $1.134B 0.00
Jyong Biotech (MENS) Taiwan $1.101B 0.00
Sana Biotechnology (SANA) United States $1.100B 0.00
Structure Therapeutics (GPCR) United States $1.048B 0.00
Pharvaris (PHVS) Netherlands $1.046B 0.00
Arcus Biosciences (RCUS) United States $1.043B 0.00
Spyre Therapeutics (SYRE) United States $1.023B 0.00
Pacira BioSciences (PCRX) United States $1.021B 9.71
MiMedx (MDXG) United States $1.003B 24.25
Anavex Life Sciences (AVXL) United States $0.988B 0.00
Iovance Biotherapeutics (IOVA) United States $0.985B 0.00
BGM Group (BGM) China $0.976B 0.00
Oric Pharmaceuticals (ORIC) United States $0.953B 0.00
Immunome (IMNM) United States $0.943B 0.00
Zymeworks (ZYME) United States $0.938B 0.00
Nurix Therapeutics (NRIX) United States $0.912B 0.00
Trevi Therapeutics (TRVI) United States $0.896B 0.00
LENZ Therapeutics (LENZ) United States $0.887B 0.00
Mineralys Therapeutics (MLYS) United States $0.886B 0.00
Sionna Therapeutics (SION) United States $0.876B 0.00
Urogen Pharma (URGN) United States $0.873B 0.00
Nuvation Bio (NUVB) United States $0.868B 0.00
NeoGenomics (NEO) United States $0.831B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.823B 0.00
UniQure (QURE) Netherlands $0.821B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.817B 0.00
CorMedix Inc (CRMD) United States $0.813B 54.46
Immatics (IMTX) Germany $0.811B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
Oculis Holding AG (OCS) Switzerland $0.782B 0.00
AnaptysBio (ANAB) United States $0.781B 0.00
GH Research (GHRS) Ireland $0.779B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Upstream Bio (UPB) United States $0.771B 0.00
Niagen Bioscience (NAGE) United States $0.763B 107.67
Vir Biotechnology (VIR) United States $0.758B 0.00
Geron (GERN) United States $0.732B 0.00
Gyre Therapeutics (GYRE) United States $0.732B 195.25
Mind Medicine (MindMed) (MNMD) United States $0.731B 0.00
Tango Therapeutics (TNGX) United States $0.723B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.720B 0.00
Dianthus Therapeutics (DNTH) United States $0.717B 0.00
Maze Therapeutics (MAZE) United States $0.717B 0.00
ArriVent BioPharma (AVBP) United States $0.716B 0.00
Stoke Therapeutics (STOK) United States $0.699B 16.22
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.690B 0.00
Zenas BioPharma (ZBIO) United States $0.688B 0.00
Pharming Group (PHAR) Netherlands $0.685B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.668B 0.00
MeiraGTx Holdings (MGTX) United States $0.661B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Bicara Therapeutics (BCAX) United States $0.644B 0.00
Arbutus Biopharma (ABUS) United States $0.642B 0.00
Fortrea Holdings (FTRE) United States $0.622B 17.17
Septerna (SEPN) United States $0.616B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.614B 0.00
Rapport Therapeutics (RAPP) United States $0.611B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.596B 0.00
Tyra Biosciences (TYRA) United States $0.590B 0.00
Keros Therapeutics (KROS) United States $0.589B 0.00
Arvinas (ARVN) United States $0.555B 0.00
Rezolute (RZLT) United States $0.555B 0.00
Prime Medicine (PRME) United States $0.550B 0.00
Sage Therapeutics (SAGE) United States $0.550B 0.00
ATyr Pharma (ATYR) United States $0.548B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.548B 0.00
Solid Biosciences (SLDB) United States $0.544B 0.00
Kura Oncology (KURA) United States $0.536B 0.00
Opthea (OPT) Australia $0.525B 0.00
Terns Pharmaceuticals (TERN) United States $0.520B 0.00
MBX Biosciences (MBX) United States $0.486B 0.00
Cullinan Therapeutics (CGEM) United States $0.486B 0.00
Erasca (ERAS) United States $0.482B 0.00
Cytek Biosciences (CTKB) United States $0.475B 0.00
Castle Biosciences (CSTL) United States $0.471B 32.02
PureTech Health (PRTC) United States $0.470B 0.00
Precigen (PGEN) United States $0.466B 0.00
Gossamer Bio (GOSS) United States $0.450B 0.00
Compass Therapeutics (CMPX) United States $0.443B 0.00
Kamada (KMDA) Israel $0.442B 26.48
REGENXBIO (RGNX) United States $0.441B 0.00
Palvella Therapeutics (PVLA) United States $0.441B 0.00
Kodiak Sciences (KOD) United States $0.435B 0.00
Tectonic Therapeutic (TECX) United States $0.425B 0.00
Fulcrum Therapeutics (FULC) United States $0.422B 0.00
Myriad Genetics (MYGN) United States $0.404B 0.00
Eton Pharmaceuticals (ETON) United States $0.403B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.394B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.390B 0.00
ITeos Therapeutics (ITOS) United States $0.387B 0.00
Vigil Neuroscience (VIGL) United States $0.384B 0.00
Humacyte (HUMA) United States $0.383B 0.00
Absci (ABSI) United States $0.379B 0.00
Astria Therapeutics (ATXS) United States $0.374B 0.00
Northwest Biotherapeutics (NWBO) United States $0.371B 0.00
Prothena (PRTA) Ireland $0.370B 0.00
Neumora Therapeutics (NMRA) United States $0.369B 0.00
Emergent Biosolutions (EBS) United States $0.368B 0.00
Foghorn Therapeutics (FHTX) United States $0.362B 0.00
Inhibrx Biosciences (INBX) United States $0.356B 0.21
Cartesian Therapeutics (RNAC) United States $0.356B 0.00
Aura Biosciences (AURA) United States $0.351B 0.00
Candel Therapeutics (CADL) United States $0.344B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.341B 69.38
Abeona Therapeutics (ABEO) United States $0.339B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.332B 0.00
Verastem (VSTM) United States $0.331B 0.00
Olema Pharmaceuticals (OLMA) United States $0.330B 0.00
Atea Pharmaceuticals (AVIR) United States $0.324B 0.00
Allogene Therapeutics (ALLO) United States $0.322B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.317B 0.00
XOMA Royalty (XOMA) United States $0.314B 0.00
Sagimet Biosciences (SGMT) United States $0.314B 0.00
Amarin (AMRN) Ireland $0.310B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.309B 0.00
Neurogene (NGNE) United States $0.309B 0.00
Vor Biopharma (VOR) $0.302B 0.00
Ocugen (OCGN) United States $0.301B 0.00
Aardvark Therapeutics (AARD) United States $0.295B 0.00
Inventiva S.A (IVA) France $0.291B 0.00
Benitec Biopharma (BNTC) United States $0.289B 0.00
ScPharmaceuticals (SCPH) United States $0.286B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.280B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.277B 0.00
Alpha Teknova (TKNO) United States $0.275B 0.00
Annexon (ANNX) United States $0.273B 0.00
Lifecore Biomedical (LFCR) United States $0.271B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.271B 0.00
DBV Technologies S.A (DBVT) France $0.267B 0.00
Monopar Therapeutics (MNPR) United States $0.265B 0.00
Prima BioMed (IMMP) Australia $0.263B 0.00
Crescent Biopharma (CBIO) United States $0.259B 0.00
Codexis (CDXS) United States $0.252B 0.00
Cardiff Oncology (CRDF) United States $0.248B 0.00
Editas Medicine (EDIT) United States $0.248B 0.00
Replimune (REPL) United States $0.247B 0.00
Third Harmonic Bio (THRD) United States $0.243B 0.00
MaxCyte (MXCT) United States $0.241B 0.00
Adherex Technologies (FENC) United States $0.240B 0.00
Bright Minds Biosciences (DRUG) United States $0.239B 0.00
AC Immune (ACIU) Switzerland $0.238B 0.00
Entrada Therapeutics (TRDA) United States $0.236B 7.69
ProQR Therapeutics (PRQR) Netherlands $0.236B 0.00
Tvardi Therapeutics (TVRD) United States $0.233B 0.00
Design Therapeutics (DSGN) United States $0.229B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.228B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.221B 0.00
Alumis (ALMS) United States $0.220B 0.00
DiaMedica Therapeutics (DMAC) United States $0.217B 0.00
Ventyx Biosciences (VTYX) United States $0.216B 0.00
Adocia (ADOCY) France $0.216B 0.00
Caribou Biosciences (CRBU) United States $0.213B 0.00
Rapt Therapeutics (RAPT) United States $0.210B 0.00
GENFIT S.A (GNFT) France $0.208B 0.00
CARGO Therapeutics (CRGX) United States $0.208B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.204B 0.00
Innate Pharma S.A (IPHA) France $0.203B 0.00
Semper Paratus Acquisition (TVGN) United States $0.199B 0.00
Instil Bio (TIL) United States $0.195B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.193B 0.00
CytomX Therapeutics (CTMX) United States $0.193B 4.98
Kyverna Therapeutics (KYTX) United States $0.187B 0.00
EnGene Holdings (ENGN) Canada $0.186B 0.00
BioStem Technologies (BSEM) $0.186B 7.55
Voyager Therapeutics (VYGR) United States $0.181B 0.00
SELLAS Life Sciences (SLS) United States $0.178B 0.00
Alector (ALEC) United States $0.176B 0.00
Agenus (AGEN) United States $0.174B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.172B 0.00
Black Diamond Therapeutics (BDTX) United States $0.167B 48.83
Puma Biotechnology (PBYI) United States $0.166B 4.34
Cuprina Holdings (Cayman) (CUPR) Singapore $0.163B 0.00
Anika Therapeutics (ANIK) United States $0.162B 0.00
BioAge Labs (BIOA) United States $0.162B 0.00
Elicio Therapeutics (ELTX) United States $0.162B 0.00
Molecular Partners AG (MOLN) Switzerland $0.159B 0.00
Nuvectis Pharma (NVCT) United States $0.159B 0.00
Cellectis S.A (CLLS) France $0.158B 0.00
IO Biotech (IOBT) Denmark $0.158B 0.00
Nkarta (NKTX) United States $0.156B 0.00
Alpha Cognition (ACOG) Canada $0.156B 0.00
C4 Therapeutics (CCCC) United States $0.155B 0.00
Greenwich LifeSciences (GLSI) United States $0.154B 0.00
I-Mab (IMAB) United States $0.152B 0.00
Fate Therapeutics (FATE) United States $0.149B 0.00
Citius Oncology (CTOR) United States $0.147B 0.00
Theratechnologies (THTX) Canada $0.145B 0.00
Contineum Therapeutics (CTNM) United States $0.143B 0.00
Immuneering (IMRX) United States $0.141B 0.00
Actuate Therapeutics (ACTU) United States $0.140B 0.00
Sangamo Therapeutics (SGMO) United States $0.140B 0.00
Compugen (CGEN) Israel $0.135B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.130B 0.00
Seer (SEER) United States $0.130B 0.00
23andMe Holding (MEHCQ) United States $0.129B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.129B 0.00
Spero Therapeutics (SPRO) United States $0.129B 0.00
Genelux (GNLX) United States $0.128B 0.00
Tenaya Therapeutics (TNYA) United States $0.127B 0.00
Coherus Oncology (CHRS) United States $0.124B 0.00
BioHarvest Sciences (BHST) Canada $0.123B 0.00
TuHURA Biosciences (HURA) United States $0.121B 0.00
Skye Bioscience (SKYE) United States $0.116B 0.00
Seres Therapeutics (MCRB) United States $0.116B 0.00
Connect Biopharma Holdings (CNTB) United States $0.116B 0.00
Zura Bio (ZURA) United States $0.111B 0.00
Coya Therapeutics (COYA) United States $0.111B 0.00
Climb Bio (CLYM) United States $0.108B 0.00
Scilex Holding (SCLX) United States $0.108B 0.00
HilleVax (HLVX) United States $0.107B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.106B 0.00
TScan Therapeutics (TCRX) United States $0.106B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.105B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.104B 0.00
Immunic (IMUX) United States $0.103B 0.00
Oncolytics Biotech (ONCY) Canada $0.103B 0.00
OKYO Pharma (OKYO) $0.103B 0.00
Invivyd (IVVD) United States $0.100B 0.00
Nautilus Biotechnology (NAUT) United States $0.099B 0.00
Pliant Therapeutics (PLRX) United States $0.098B 0.00
Quince Therapeutics (QNCX) United States $0.097B 0.00
Adagene (ADAG) China $0.094B 0.00
Entera Bio (ENTX) Israel $0.094B 0.00
VistaGen Therapeutics (VTGN) United States $0.093B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.088B 0.00
XBiotech (XBIT) United States $0.086B 0.00
Cabaletta Bio (CABA) United States $0.086B 0.00
Whitehawk Therapeutics (WHWK) United States $0.085B 0.00
Alto Neuroscience (ANRO) United States $0.084B 0.00
EXoZymes (EXOZ) United States $0.083B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.083B 0.00
Elutia (ELUT) United States $0.081B 0.00
Celularity (CELU) United States $0.079B 0.00
BeyondSpring (BYSI) United States $0.077B 0.00
Forte Biosciences (FBRX) United States $0.077B 0.00
Immix Biopharma (IMMX) United States $0.076B 0.00
IGM Biosciences (IGMS) United States $0.076B 0.00
CervoMed (CRVO) United States $0.075B 0.00
TELA Bio (TELA) United States $0.075B 0.00
MiNK Therapeutics (INKT) United States $0.075B 0.00
Quantum Biopharma (QNTM) Canada $0.072B 0.00
Sutro Biopharma (STRO) United States $0.072B 0.00
Artiva Biotherapeutics (ARTV) United States $0.072B 0.00
Opus Genetics (IRD) United States $0.072B 0.00
MediciNova (MNOV) United States $0.071B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
Atara Biotherapeutics (ATRA) United States $0.070B 0.00
Applied Therapeutics (APLT) United States $0.069B 0.00
INmune Bio (INMB) United States $0.069B 0.00
Repare Therapeutics (RPTX) Canada $0.068B 0.00
Biomea Fusion (BMEA) United States $0.068B 0.00
Oncobiologics (OTLK) United States $0.067B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.063B 0.00
Adicet Bio (ACET) United States $0.062B 0.00
Cue Biopharma (CUE) United States $0.062B 0.00
Werewolf Therapeutics (HOWL) United States $0.061B 0.00
InflaRx (IFRX) Germany $0.059B 0.00
Fortress Biotech (FBIO) United States $0.059B 0.00
Annovis Bio (ANVS) United States $0.057B 0.00
Precision BioSciences (DTIL) United States $0.057B 0.00
Adverum Biotechnologies (ADVM) United States $0.055B 0.00
Kalaris Therapeutics (KLRS) United States $0.055B 0.00
Inovio Pharmaceuticals (INO) United States $0.054B 0.00
Renovaro (RENB) United States $0.054B 0.00
PDS Biotechnology (PDSB) United States $0.054B 0.00
Aligos Therapeutics (ALGS) United States $0.054B 0.00
Adlai Nortye (ANL) Cayman Islands $0.052B 0.00
CalciMedica (CALC) United States $0.052B 0.00
Earth Science Tech (ETST) United States $0.052B 0.00
ABVC BioPharma (ABVC) United States $0.051B 0.00
KALA BIO (KALA) United States $0.051B 0.00
VTv Therapeutics (VTVT) United States $0.050B 0.00
Alterity Therapeutics - (ATHE) Australia $0.049B 0.00
Senti Biosciences (SNTI) United States $0.049B 0.00
PepGen (PEPG) United States $0.047B 0.00
Jasper Therapeutics (JSPR) United States $0.047B 0.00
RenovoRx (RNXT) United States $0.046B 0.00
Exicure (XCUR) United States $0.046B 0.00
Cognition Therapeutics (CGTX) United States $0.044B 0.00
Lantern Pharma (LTRN) United States $0.043B 0.00
Pluri (PLUR) Israel $0.042B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.042B 0.00
Grace Therapeutics (GRCE) Canada $0.042B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.040B 0.00
Shattuck Labs (STTK) United States $0.039B 0.00
Ovid Therapeutics (OVID) United States $0.038B 0.00
Radiopharm Theranostics - (RADX) Australia $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
CAMP4 Therapeutics (CAMP) United States $0.035B 0.00
Rani Therapeutics Holdings (RANI) United States $0.035B 0.00
Clearside Biomedical (CLSD) United States $0.035B 0.00
Mersana Therapeutics (MRSN) United States $0.034B 0.00
ALX Oncology Holdings (ALXO) United States $0.033B 0.00
Dyadic (DYAI) United States $0.033B 0.00
Estrella Immunopharma (ESLA) United States $0.033B 0.00
Medicus Pharma (MDCX) United States $0.033B 0.00
AN2 Therapeutics (ANTX) United States $0.032B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.032B 0.00
Kezar Life Sciences (KZR) United States $0.032B 0.00
Generation Bio (GBIO) United States $0.032B 0.00
Rein Therapeutics (RNTX) United States $0.031B 0.00
OnKure Therapeutics (OKUR) United States $0.031B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.030B 0.00
Promis Neurosciences (PMN) Canada $0.029B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.029B 0.00
Femasys (FEMY) United States $0.028B 0.00
Clene (CLNN) United States $0.028B 0.00
Boundless Bio (BOLD) United States $0.028B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.028B 0.00
Q32 Bio (QTTB) United States $0.027B 0.00
Cingulate (CING) United States $0.027B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.027B 0.00
FibroBiologics (FBLG) United States $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.026B 0.00
Longeveron (LGVN) United States $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.024B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.024B 0.00
Aytu BioPharma (AYTU) United States $0.024B 0.00
SAB Biotherapeutics (SABS) United States $0.024B 0.00
Dare Bioscience (DARE) United States $0.023B 0.00
Cadrenal Therapeutics (CVKD) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Passage Bio (PASG) United States $0.022B 0.00
Rallybio (RLYB) United States $0.021B 0.00
BioAtla (BCAB) United States $0.021B 0.00
Chemomab Therapeutics (CMMB) Israel $0.021B 0.00
Abpro Holdings (ABP) United States $0.019B 0.00
Curis (CRIS) United States $0.019B 0.00
Synlogic (SYBX) United States $0.019B 0.00
180 Life Sciences (ATNF) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Gelteq (GELS) Australia $0.017B 0.00
Allarity Therapeutics (ALLR) United States $0.017B 0.00
Moleculin Biotech (MBRX) United States $0.017B 0.00
Edesa Biotech (EDSA) Canada $0.016B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.016B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Equillium (EQ) United States $0.016B 0.00
NextCure (NXTC) United States $0.015B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
MetaVia (MTVA) United States $0.013B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.013B 0.00
BioCardia (BCDA) United States $0.013B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.012B 0.00
X4 Pharmaceuticals (XFOR) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
IBio (IBIO) United States $0.012B 0.00
Advanced Biomed (ADVB) United States $0.012B 0.00
HOOKIPA Pharma (HOOK) United States $0.011B 0.00
Bionano Genomics (BNGO) United States $0.011B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.011B 0.00
Biofrontera (BFRI) United States $0.011B 0.00
Aprea Therapeutics (APRE) United States $0.010B 0.00
BioXcel Therapeutics (BTAI) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Artelo Biosciences (ARTL) United States $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Synaptogenix (TAOX) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
Novogen (KZIA) Australia $0.009B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Polyrizon (PLRZ) Israel $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Jade Biosciences (JBIO) United States $0.007B 0.00
Portage Biotech (PRTG) $0.006B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
Palisade Bio (PALI) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
VivoSim Labs (VIVS) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Psyence Biomedical (PBM) Canada $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Revelation Biosciences (REVB) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Alzamend Neuro (ALZN) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00